Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Monkton Inc. Hires Dr. Johnathan Jordan as Chief Data Officer to Lead AI and Machine Learning Thought Leadership
-
Falco Commences Broad Exploration Program Across the Noranda Camp
-
Inc. Honors DiGennaro Communications as a 2025 Power Partner for Driving Entrepreneurial Growth
-
Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia
-
ACTO UNVEILS ACTOVERSE: A PARTNER SOLUTIONS MARKETPLACE DRIVING INNOVATION AND EFFICIENCY IN FIELD EXCELLENCE AT VEEVA COMMERCIAL SUMMIT EUROPE
-
Blockchain Futurist Conference Announces 2026 Toronto Dates: July 21-22, 2026
-
goHappy Launches Rewards Feature to Help Employers Recognize and Celebrate Frontline Workers
-
Carver Bancorp, Inc. Announces Board Modernization Initiative with Comprehensive Governance Enhancements
-
Parker Institute for Cancer Immunotherapy Demonstrates Leadership and Showcases Latest Advances in Immunotherapy at SITC 2025 Annual Meeting
-
PainReform’s DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link’s “Watchlist Interview” and Announces Progress Toward Pilot Projects
-
Petauri Announces Leadership Transition for Petauri Advance
-
Streamlining Cell Line Development for Faster Biologics Production, Upcoming Webinar Hosted by Xtalks
-
Enhancing Cardiometabolic Trials with Configurable eCOA and Digital Health Technologies, Upcoming Webinar Hosted by Xtalks
-
Veris Residential Declares Fourth Quarter 2025 Cash Dividend
-
Engineering Peptide Stability Through Azapeptide Synthesis and Applications, Upcoming Webinar Hosted by Xtalks
-
Pinpoint Clinical Trial Participants with Precision Feasibility and RWD, Upcoming Webinar Hosted by Xtalks
-
SWIRL Joins iManage Technology Partner Program, Expanding Customer Choice for Secure, AI-Powered Knowledge Discovery
-
Normunity announces first patient dosed in Phase 1 clinical study of NRM-823, a T Cell Engager against a novel tumor-specific target, in patients with solid tumors
-
Walbridge Earns Supplier of the Year Award from Stellantis for Operational Excellence
-
Sketches from A Life: Memoir by Former Congressman Lincoln Díaz-Balart Now Available
-
Corporación América Airports Signs Award Agreement to Operate Baghdad International Airport
-
XPEL Reports Revenue Growth of 11.1% to $125.4 million in Third Quarter 2025; Announces Strategic Investments in Manufacturing and Supply Chain
-
Snyk and Factory Partner to Secure AI-Native Development, Prioritizing Speed and Security
-
Tempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025
-
Zuper Launches the First AI-Powered Smart Glasses Built for the Skilled Trades
-
Intercontinental Exchange Reports October Statistics
-
HCA Healthcare Announces $1.5 Million HCA Healthcare Foundation Grant to Support March of Dimes' Low Dose, Big Benefits™ Campaign
-
Fathom Holdings Begins Expansion of START Real Estate
-
The ONE Group Hospitality, Inc. to Host Third Quarter 2025 Earnings Conference Call and Webcast at 4:30 PM ET on November 6, 2025
-
StratumFi Unveils Multi-Layer Interoperability Architecture, Redefining the Future of DeFi Infrastructure
-
Boosting Productivity Through Financial Wellness: Employers Invest in Emergency Savings Benefits
-
Vistagen to Participate in Stifel Healthcare Conference 2025
-
Quad to Present at the Southwest IDEAS Investor Conference on November 19
-
TRWD Launches Media Campaign to Expand Brand Visibility Across North America and Latin America
-
Vantage Corp Announces $1 Million Share Repurchase Program
-
CrowdStrike Announces Date of Fiscal Third Quarter 2026 Financial Results Conference Call
-
Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease
-
TruGolf Re-imagines the Driving Range:
-
VisionWave Holdings Files Complaints with Nasdaq and FINRA Regarding Abnormal Market Activity; Company Engages Multiple Law Firms and Places Market Makers on Notice
-
Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia
-
YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA‑Methylation Blood Test for Post‑Treatment Breast Cancer Monitoring
-
Unwrap Unbeatable Deals This Season at Grocery Outlet, Your Xtreme Value™ Holiday Headquarters
-
iAnthus Continues Expansion in Florida with GrowHealthy Dispensary Opening in Fort Myers
-
Tempest Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
-
Project C.U.R.E. Bridge the Global Healthcare Divide with Mission-Driven Innovation with Microsoft
-
EuroHoldings Ltd. Announces Agreement to Acquire one 49,997 DWT Product Tanker Vessel, M/T Hellas Avatar, built in 2015
-
KraneShares Launches KWIN: An Alternative Income Index ETF With Wahed Invest LLC
-
Pure Cycle Corporation Announces Dates for Year End 2025 Earnings Presentation
-
Connecting Brands With Purpose-Driven Audiences: 3BL's 2025 Network Expansion
